203 related articles for article (PubMed ID: 29670631)
1. X-Linked Lymphoproliferative Disease Type 1: A Clinical and Molecular Perspective.
Panchal N; Booth C; Cannons JL; Schwartzberg PL
Front Immunol; 2018; 9():666. PubMed ID: 29670631
[TBL] [Abstract][Full Text] [Related]
2. Single-Cell Transcriptomic Analysis of Epstein-Barr Virus-Associated Hemophagocytic Lymphohistiocytosis.
Suzuki T; Sato Y; Okuno Y; Torii Y; Fukuda Y; Haruta K; Yamaguchi M; Kawamura Y; Hama A; Narita A; Muramatsu H; Yoshikawa T; Takahashi Y; Kimura H; Ito Y; Kawada JI
J Clin Immunol; 2024 Apr; 44(4):103. PubMed ID: 38642164
[TBL] [Abstract][Full Text] [Related]
3. X-Linked Lymphoproliferative Syndrome: A Spectrum of Clinical and Immunological Profile and Novel Pathogenic Variants from Chandigarh, India.
Jindal AK; Mondal S; Sil A; Rawat A; Chawla S; Tyagi R; Sudhakar M; Banday AZ; Suri D; Vignesh P; Dhaliwal M; Sharma S; Rikhi R; Saka R; Sharma R; Chatterjee D; Sreedharanunni S; Uppuluri R; Raj R; Singh S
Int Arch Allergy Immunol; 2024; 185(4):370-381. PubMed ID: 38194943
[TBL] [Abstract][Full Text] [Related]
4. Case report: Non-EBV associated cerebral vasculitis and cerebral hemorrhage in X-linked lymphoproliferative disease.
Li B; Chen W; Cai X; Hai Y; Pang Q; Xiang W; Zhang Z
Front Immunol; 2024; 15():1381472. PubMed ID: 38726008
[TBL] [Abstract][Full Text] [Related]
5. X-linked lymphoproliferative syndrome associated with Epstein-Barr virus encephalitis and lymphoproliferative disorder.
Mukai T; Waki K
Clin Case Rep; 2023 Sep; 11(9):e7949. PubMed ID: 37744615
[TBL] [Abstract][Full Text] [Related]
6. Use of Genetic Testing for Primary Immunodeficiency Patients.
Heimall JR; Hagin D; Hajjar J; Henrickson SE; Hernandez-Trujillo HS; Tan Y; Kobrynski L; Paris K; Torgerson TR; Verbsky JW; Wasserman RL; Hsieh EWY; Blessing JJ; Chou JS; Lawrence MG; Marsh RA; Rosenzweig SD; Orange JS; Abraham RS
J Clin Immunol; 2018 Apr; 38(3):320-329. PubMed ID: 29675737
[TBL] [Abstract][Full Text] [Related]
7. Inherited Immunodeficiencies With High Predisposition to Epstein-Barr Virus-Driven Lymphoproliferative Diseases.
Latour S; Winter S
Front Immunol; 2018; 9():1103. PubMed ID: 29942301
[TBL] [Abstract][Full Text] [Related]
8. Predictive markers for humoral influenza vaccine response in patients with common variable immunodeficiency.
Gardulf A; Abolhassani H; Gustafson R; Eriksson LE; Hammarström L
J Allergy Clin Immunol; 2018 Dec; 142(6):1922-1931.e2. PubMed ID: 29678747
[TBL] [Abstract][Full Text] [Related]
9. X-linked lymphoproliferative syndrome in mainland China: review of clinical, genetic, and immunological characteristic.
Xu T; Zhao Q; Li W; Chen X; Xue X; Chen Z; Du X; Bai X; Zhao Q; Zhou L; Tang X; Yang X; Kanegane H; Zhao X
Eur J Pediatr; 2020 Feb; 179(2):327-338. PubMed ID: 31754776
[TBL] [Abstract][Full Text] [Related]
10. Pathobiology and treatment of lymphomatoid granulomatosis, a rare EBV-driven disorder.
Melani C; Jaffe ES; Wilson WH
Blood; 2020 Apr; 135(16):1344-1352. PubMed ID: 32107539
[TBL] [Abstract][Full Text] [Related]
11. Vaccine Development for Epstein-Barr Virus.
Cohen JI
Adv Exp Med Biol; 2018; 1045():477-493. PubMed ID: 29896681
[TBL] [Abstract][Full Text] [Related]
12. Rare cause of Hemophagocytic Lymphohistiocytosis due to mutation in PRF1 and SH2D1A genes in two children - a case report with a review.
Sheth J; Patel A; Shah R; Bhavsar R; Trivedi S; Sheth F
BMC Pediatr; 2019 Mar; 19(1):73. PubMed ID: 30849948
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic challenges for a novel SH2D1A mutation associated with X-linked lymphoproliferative disease.
Torralba-Raga L; Tesi B; Chiang SCC; Schlums H; Nordenskjöld M; Horne A; Henter JI; Meeths M; Abdelhaleem M; Weitzman S; Bryceson Y
Pediatr Blood Cancer; 2020 Apr; 67(4):e28184. PubMed ID: 31994322
[TBL] [Abstract][Full Text] [Related]
14. Pediatric hemophagocytic lymphohistiocytosis.
Canna SW; Marsh RA
Blood; 2020 Apr; 135(16):1332-1343. PubMed ID: 32107531
[TBL] [Abstract][Full Text] [Related]
15. Transfer of gene-corrected T cells corrects humoral and cytotoxic defects in patients with X-linked lymphoproliferative disease.
Panchal N; Houghton B; Diez B; Ghosh S; Ricciardelli I; Thrasher AJ; Gaspar HB; Booth C
J Allergy Clin Immunol; 2018 Jul; 142(1):235-245.e6. PubMed ID: 29705247
[TBL] [Abstract][Full Text] [Related]
16. The X-linked lymphoproliferative-disease gene product SAP regulates signals induced through the co-receptor SLAM.
Sayos J; Wu C; Morra M; Wang N; Zhang X; Allen D; van Schaik S; Notarangelo L; Geha R; Roncarolo MG; Oettgen H; De Vries JE; Aversa G; Terhorst C
Nature; 1998 Oct; 395(6701):462-9. PubMed ID: 9774102
[TBL] [Abstract][Full Text] [Related]
17. Case report: EBV-related eye orbits and sinuses lymphohistiocytic infiltration responsive to rituximab in a patient with X lymphoproliferative syndrome type 1.
Giardino G; Lanni V; Mascolo M; Russo D; Cirillo E; Romano R; Cillo F; Grilli L; Prencipe MR; Iuliano A; Uccello G; De Fusco C; Menna G; Scalia G; Portella G; Pignata C
Front Immunol; 2024; 15():1370991. PubMed ID: 38633254
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
